Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Clinical trial NCT04633902 · UNKNOWN
Trial details
- NCT number
- NCT04633902
- Sponsor
- California Pacific Medical Center Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2023-06-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.